Rydex Biotechnology Fund Class H (RYOAX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
47.31
-0.97 (-2.01%)
May 9, 2025, 4:00 PM EDT
-19.84% (1Y)
| Fund Assets | 117.21M |
| Expense Ratio | 1.65% |
| Min. Investment | $2,500 |
| Turnover | n/a |
| Dividend (ttm) | 9.42 |
| Dividend Yield | 19.92% |
| Dividend Growth | n/a |
| Payout Frequency | n/a |
| Ex-Dividend Date | Dec 12, 2024 |
| Previous Close | 48.28 |
| YTD Return | -8.44% |
| 1-Year Return | -5.85% |
| 5-Year Return | -3.60% |
| 52-Week Low | n/a |
| 52-Week High | n/a |
| Beta (5Y) | n/a |
| Holdings | 80 |
| Inception Date | Apr 1, 1998 |
About RYOAX
The Fund's investment strategy focuses on Health/Biotech with 1.73% total expense ratio. The minimum amount to invest in Rydex Series Funds: Biotechnology Fund; Class H Shares is $2,500 on a standard taxable account. Rydex Series Funds: Biotechnology Fund; Class H Shares seeks capital appreciation by investing in companies that are involved in the biotechnology industry.
Fund Family Rydex H Class
Category Health
Performance Rating Below Average
Risk Rating Above Average
Stock Exchange NASDAQ
Ticker Symbol RYOAX
Share Class Class H
Index S&P 500 TR
Performance
RYOAX had a total return of -5.85% in the past year, including dividends. Since the fund's inception, the average annual return has been 8.83%.
Equivalent Funds
These are funds that follow the same index from the other major fund companies.
| Symbol | Provider | Name | Expense Ratio |
|---|---|---|---|
| FIKCX | Fidelity | Fidelity Advisor Health Care Fund - Class Z | 0.59% |
| FSPHX | Fidelity | Fidelity Select Health Care Portfolio | 0.63% |
| FIJYX | Fidelity | Fidelity Advisor Biotechnology Fund - Class Z | 0.61% |
| FACDX | Fidelity | Fidelity Advisor Health Care Fund - Class A | 0.98% |
| FSHCX | Fidelity | Fidelity Select Health Care Services Portfolio | 0.67% |
Top 10 Holdings
41.01% of assets| Name | Symbol | Weight |
|---|---|---|
| AbbVie Inc. | ABBV | 9.13% |
| Amgen Inc. | AMGN | 5.92% |
| Gilead Sciences, Inc. | GILD | 5.74% |
| Vertex Pharmaceuticals Incorporated | VRTX | 4.43% |
| Regeneron Pharmaceuticals, Inc. | REGN | 3.66% |
| Corteva, Inc. | CTVA | 2.92% |
| AstraZeneca PLC | AZN | 2.49% |
| Alnylam Pharmaceuticals, Inc. | ALNY | 2.41% |
| First American Government Obligations Fund | FGXXX | 2.24% |
| Royalty Pharma plc | RPRX | 2.07% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Dec 12, 2024 | $9.42277 | Dec 12, 2024 |
| Dec 20, 2022 | $0.89943 | Dec 20, 2022 |
| Dec 8, 2021 | $15.77303 | Dec 8, 2021 |
| Dec 9, 2020 | $6.95038 | Dec 9, 2020 |
| Dec 10, 2019 | $3.60206 | Dec 10, 2019 |
| Dec 11, 2018 | $9.88842 | Dec 11, 2018 |